Skip to main content
Global Hemp Group Inc. logo

Global Hemp Group Inc. — Investor Relations & Filings

Ticker · GHG ISIN · CA37953Y1043 LEI · 5299002P2ETND2KOY311 CSE Manufacturing
Open in API
Filings indexed 350 across all filing types
Latest filing 2021-01-18 Capital/Financing Update
Country CA Canada
Listing CSE GHG

About Global Hemp Group Inc.

https://globalhempgroup.com/

Global Hemp Group Inc. focuses on two key segments: Industrial Hemp and Biopharma. The Industrial Hemp division develops innovative, green, and sustainable solutions utilizing the whole hemp plant for environmental applications, including carbon-negative construction materials, sustainable bio-energy sources, bio-composites, textiles, and nonwovens. This strategy is executed through the Hemp Agro-Industrial Zone (HAIZ) concept, which integrates raw material supply with industrial processing. The company also maintains an R&D division dedicated to developing patented IP for hemp-based eco-friendly building materials. The Biopharma division centers on acquiring exclusive licensing of advanced Intellectual Property, notably holding exclusive perpetual licenses to Apollon Formularies' proprietary technology and patents for developing cancer treatments from natural biologics (such as medical cannabis and functional mushrooms) using an AI-based drug discovery platform.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing that Global Hemp Group Inc. has signed a binding Letter of Intent to acquire control over strategic water infrastructure assets in Colorado. It details the transaction terms, share issuance, warrants, and restructuring plans. There is no indication that this is a financial report, earnings release, or regulatory filing such as an annual or interim report. The content focuses on a capital transaction and financing arrangement involving share issuance and warrants. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length (8374 characters) and detailed transaction information support this classification with high confidence.
2021-01-18 English
Report of exempt distribution excluding schedule 1 of Form 5.pdf
Regulatory Filings Classification · 90% confidence The document contains only references to omitted pictures and no textual content or financial data. The total character count is 1209, which is very short and does not contain any report or announcement text. There is no indication of the document being a report itself or an announcement of a report. Given the lack of content and the nature of the document, it does not fit any specific report category and defaults to Regulatory Filings (RNS) as a fallback category.
2020-12-18 English
Report of exempt distribution excluding schedule 1 of Form 5.pdf
Regulatory Filings Classification · 100% confidence The document is titled 'Form 45-106F1 Report of Exempt Distribution' and contains detailed filing instructions related to exempt distributions in Canadian jurisdictions. It includes regulatory references such as National Instrument 45-106 and instructions for filing with Canadian securities regulators. The content is a regulatory form used for reporting exempt distributions of securities, not a financial report, earnings release, or management discussion. It is a regulatory filing form used for compliance purposes. Therefore, the document fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory compliance documents that do not fit other specific categories.
2020-12-10 English
News release - English.pdf
Regulatory Filings
2020-12-08 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the expansion of the company's hemp R&D team in Mexico, the appointment of a new team member, a short-term loan received, and the issuance of stock options to advisors. It contains no financial statements, no detailed financial performance data, no regulatory certifications, or voting results. It is primarily an operational and financing update with details on capital structure changes (loan and stock options issuance). The document length is 6726 characters, which is sufficient for a substantive announcement. The content fits best under Capital/Financing Update (CAP) because it includes financing activity (loan) and issuance of options, which are capital structure changes. It is not an earnings release or annual/interim report, nor a regulatory filing or management report. Therefore, the classification is CAP with high confidence.
2020-11-27 English
Report of exempt distribution excluding schedule 1 of Form 5.pdf
Regulatory Filings Classification · 100% confidence The document is titled 'Form 45-106F1 Report of Exempt Distribution' and contains detailed instructions and fields related to filing reports of exempt distributions in Canadian jurisdictions. It includes regulatory references to Canadian securities commissions, filing instructions, and detailed data fields for issuers and underwriters. This form is a regulatory filing used to report exempt distributions of securities, which is a compliance and disclosure document rather than a financial report, earnings release, or management discussion. It does not contain financial statements or management analysis but is a regulatory compliance form. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory compliance documents that do not fit other specific categories.
2020-10-07 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.